Instructions for Authors
The Malaysian Orthopaedic Journal (MOJ) is the official publication of Malaysian Orthopaedic Association (MOA) and ASEAN Orthopaedic Association (AOA). It is a peer- reviewed journal that publishes review articles, original papers, case reports, letters to the editor and special articles. Articles are published in print and online. They are citable with the digital object identifier number (DOI).
Though the Journal has been compiled with great care, the Journal disclaims any duty to investigate any information, procedures, design and the like which may have been described in the Journal. The appearance of any information in this Journal does not guarantee the publication is free from errors and the opinion, and statements expressed are not necessarily endorsed by the Journal.
A1: Open Access
Malaysian Orthopaedic Journal is an Open Access journal published under terms and conditions of Creative Commons Attribution 4.0 International Public License (CC BY 4.0). Readers are free to read, print, share and adapt the published material in any medium and for any purpose as long as appropriate attribution are made to the contributors. Authors retain the copy-right of the published material. There is no fee for submitting articles, and no article processing charges (APC) if the article is accepted for publication.
There is no fee for submitting articles, and no article processing charges (APC) if the article is accepted for publication.
For additional information on Creative Commons licenses visit their website: (http://creativecommons.org )
MOJ adheres to the guidelines on authorship outlined by the International Committee of Medical Journal Editors (ICMJE) in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Authors should have participated sufficiently in the work to take public responsibility for the content of the article published. Addition, deletion or re-arrangement of author names in the authorship list can only be suggested by the corresponding author with a request letter addressed to the chief editor. For this purpose, the corresponding author have to provide a statement describing the responsibilities of all co-authors in the preparation of the article. Generally, such request after the article have been accepted for publication will not be considered.
B. Editorial Policy
B1: Preliminary checking
All submitted manuscripts will be checked for adherence to format and degree of duplication. They may be rejected, or returned for improvement without being assigned to manuscript editor or peer reviewer.
B2: Peer review
Following the preliminary checking, the manuscript will subsequently be assigned to a manuscript editor for scientific evaluation. The manuscript may be rejected due to wrong field of specialty, poor study design, or poor language or presentation. MOJ performs double blind peer review process to evaluate original articles and case reports. Identities of the authors will be concealed from the peer reviewers, and vice versa.
The article must be original, has not been previously published either in printed or electronic form, and is not under consideration for publication elsewhere. MOJ does not accept duplicate submission or publication. Duplicate submission refers to submitting manuscript to more than one journal at the same time. Duplicate publication refers to publication of material that significantly overlapped with articles that have already been published by the same authors, without clear reference to the latter. Previous publication in the form of abstract are not considered as duplication).
Plagiarism refers to the practice of taking someone else's work or ideas and presenting them as one's own. Authors wishing to include figures or tables that have already been published by others are required to obtain written permission from the copyright owner. Evidence that such permission has been granted must be submitted together with the manuscript.
B5: Form for Disclosure
Corresponding author must submit the ICMJE Uniform Disclosure Form for Potential Conflicts of Interest for the submission. Authors can access the interactive disclosure PDF form at the link below. After completing the form electronically, you can save the file before submitting to the journal as an attachment.
C: Instructions for submitting original scientific papers
General Format of Manuscript
Our journal online submission system will guide you stepwise through the process of entering your article details and uploading your files. The system will convert the files to a single PDF file for further evaluation.
The manuscript should be prepared using size 12 point font Times New Roman throughout (including abstracts, references, tables and illustrations). The text should be “left hand” justified only. Measurement should use SI units. Spell out “one” to “ten” at the beginning of a sentence, and “one” at all times. Arabic numerals should be used otherwise. Generic names of drugs should be used. For specific implants, instruments and devices, the manufacturer, city, and country should be provided in square brackets. Describe the chemicals and drugs used (including generic names, dosages and routes of administration).
All pages should be numbered on the top right corner. Each of the main section headings should begin with a new page. Other than the main section headings, subheadings are not recommended. Avoid presenting the main content of the study or report in “note form” (using bullets or numerals), except in title page, references, and listing legends for illustrations.
The manuscript should be written in good English language (preferably British / United Kingdom). Please perform spelling and grammar check of the text document. We strongly advise authors to use the service of professional language editors to eliminate possible grammatical or spelling errors, and to conform to correct scientific English.
C1: Title page
Title page should be submitted as a separate file. All the authors will need to provide their highest academic qualifications, affiliations, and email addresses. We will contact all authors by email to confirm their participation in the study / report before we proceed with editing process. Starting from the July 2015 issue, author's names will be published as [Family/Surname/Last name] followed by initials of [Given/First name].
Acknowledgement statement should be listed in the title page. This is to recognize those who contributed to the study or preparation of the manuscript, but not justified to be an author per se. If the study was supported by any grant, please state the grant number and name of institution / organization providing it.
Title of the article should reflect the main theme/subject and a “hint” of the outcome and this may be in a question form. E.g. Does Percutaneous Release of Trigger Finger yield better Long-term Outcome than Open Release?
- The abstract should consist not more than 350 words.
- Both structured and unstructured abstracts are acceptable.
- For original articles, result and conclusion should be included.
- Below the abstract, provide not more than 5 keywords or short phrases to assist in cross indexing of the article.
- Provide only relevant information and references
- Do not review the subject extensively.
- Do not provide more than five (5) references to support a single finding or opinion.
- State the purpose of the study clearly.
C4: Material and method
- Specify the selection of subjects or study groups clearly.
- Describe the methods, apparatus (including manufacturer’s name in parenthesis) and procedures in sufficient detail to allow others to reproduce the study.
- Provide reference to established methods, brief descriptions for methods that are not well-known.
- Describe new or substantially modified methods, giving reasons for using them and evaluate their limitations
- Describe statistical methods used with adequate details to enable a knowledgeable reader to verify the reported results.
- When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 1983.
- When reporting experiments on animals, indicate whether the institution’s or a national research council’s guide for, or any national law on, the care and use of laboratory animals was followed.
- Approval by institutional ethics committee or national ethics authority for compliance with the above.
- For descriptive analyses, report the endpoint / outcome with either measure of central tendency (mean or range) and measure of dispersion (standard deviation or range).
- Univariate analyses should be used to describe the association between independent variables with the outcome. Multiple variable analyses should be used to describe the association between all the clinically relevant variables with the outcome.
- To report a statistical difference as “significant”, it must be supported with a p value (probability) or, preferably, the 95% confidence interval about a point estimate.